KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression

Yuji Fujita; Kiyoshi Masuda; Junichi Hamada; Katsutoshi Shoda; Takuya Naruto; Satoshi Hamada; Yuko Miyakami; Tomohiro Kohmoto; Miki Watanabe; Rizu Takahashi; Shoichiro Tange; Masako Saito; Yasusei Kudo; Hitoshi Fujiwara; Daisuke Ichikawa; Akira Tangoku; Eigo Otsuji; Issei Imoto

doi:10.18632/oncotarget.20926

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression

Yuji Fujita, Kiyoshi Masuda, Junichi Hamada, Katsutoshi Shoda, Takuya Naruto, Satoshi Hamada, Yuko Miyakami, Tomohiro Kohmoto, Miki Watanabe, Rizu Takahashi, Shoichiro Tange, Masako Saito, Yasusei Kudo, Hitoshi Fujiwara, Daisuke Ichikawa, Akira Tangoku, Eigo Otsuji and Issei Imoto _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:101130-101145. https://doi.org/10.18632/oncotarget.20926

Metrics: PDF 2122 views | HTML 2646 views | ?

Abstract

Yuji Fujita1,2,*, Kiyoshi Masuda1,*, Junichi Hamada1,2,*, Katsutoshi Shoda1,2, Takuya Naruto1, Satoshi Hamada1, Yuko Miyakami1, Tomohiro Kohmoto1, Miki Watanabe1, Rizu Takahashi1, Shoichiro Tange1, Masako Saito1, Yasusei Kudo3, Hitoshi Fujiwara2, Daisuke Ichikawa2,4, Akira Tangoku5, Eigo Otsuji2 and Issei Imoto1

1Department of Human Genetics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

2Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan

3Department of Oral Molecular Pathology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

4First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan

5Department of Thoracic, Endocrine Surgery and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

*These authors contributed equally to this work

Correspondence to:

Issei Imoto, email: [email protected]

Keywords: KHSRP, oncogene, RNA-binding protein, microRNA, esophageal squamous cell carcinoma

Received: June 22, 2017 Accepted: August 25, 2017 Published: September 15, 2017

ABSTRACT

KH-type splicing regulatory protein (KHSRP) is a multifunctional RNA-binding protein, which is involved in several post-transcriptional aspects of RNA metabolism, including microRNA (miRNA) biogenesis. It affects distinct cell functions in different tissues and can have an impact on various pathological conditions. In the present study, we investigated the oncogenic functions of KHSRP and their underlying mechanisms in the pathogenesis of esophageal squamous cell carcinoma (ESCC). KHSRP expression levels were elevated in ESCC tumors when compared with those in non-tumorous tissues by immunohistochemistry, and cytoplasmic KHSRP overexpression was found to be an independent prognosticator for worse overall survival in a cohort of 104 patients with ESCC. KHSRP knockdown inhibited growth, migration, and invasion of ESCC cells. KHSRP knockdown also inhibited the maturation of cancer-associated miRNAs, such as miR-21, miR-130b, and miR-301, and induced the expression of their target mRNAs, such as BMP6, PDCD4, and TIMP3, resulting in the inhibition of epithelial-to-mesenchymal transition. Our findings uncover a novel oncogenic function of KHSRP in esophageal tumorigenesis and implicate its use as a marker for prognostic evaluation and as a putative therapeutic target in ESCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20926

Publication Alerts

Research Papers:

KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression

Abstract